Marinomed Biotech AG (STU:93Z) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Marinomed Biotech AG Price-to-Operating-Cash-Flow?

As of today (2024-06-03), Marinomed Biotech AG's share price is €14.05. Marinomed Biotech AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.09. Hence, Marinomed Biotech AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Marinomed Biotech AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:93Z's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.2
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Marinomed Biotech AG's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.61. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.09.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 9.60% per year.

During the past 9 years, Marinomed Biotech AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 13.90% per year. The lowest was -96.70% per year. And the median was -20.20% per year.

Marinomed Biotech AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Marinomed Biotech AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinomed Biotech AG Price-to-Operating-Cash-Flow Chart

Marinomed Biotech AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Marinomed Biotech AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Marinomed Biotech AG's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Marinomed Biotech AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marinomed Biotech AG's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's Price-to-Operating-Cash-Flow falls into.

Marinomed Biotech AG Price-to-Operating-Cash-Flow Calculation

Marinomed Biotech AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	14.05	/	-3.093
	=

Marinomed Biotech AG's Share Price of today is €14.05.
Marinomed Biotech AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.09.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Marinomed Biotech AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinomed Biotech AG (STU:93Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

MARI:Austria

Address

Hovengasse 25, Korneuburg, AUT, 2100

Website

https://www.marinomed.com

Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.

Marinomed Biotech AG (STU:93Z) Headlines

No Headlines